United States · FDA National Drug Code directory

Lubiprostone

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82804-001_34c547c4-4c29-45a9-97c7-a828bf2ecde0
Product NDC
82804-001
Form
CAPSULE, GELATIN COATED
Composition / generic term
Lubiprostone
Labeler
Proficient Rx LP
Marketing category
NDA AUTHORIZED GENERIC
Marketing start / end (source format)
20230101
Source listing expiry
20261231

Source-listed ingredients

  • LUBIPROSTONE — 24 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, GELATIN COATED in 1 BOTTLE (82804-001-30) · 82804-001-30
  • 60 CAPSULE, GELATIN COATED in 1 BOTTLE (82804-001-60) · 82804-001-60
  • 90 CAPSULE, GELATIN COATED in 1 BOTTLE (82804-001-90) · 82804-001-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →